trending Market Intelligence /marketintelligence/en/news-insights/trending/qks7L_1sTdLwMQ2391auJg2 content esgSubNav
In This List

Sanofi expands French vaccine production site

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Sanofi expands French vaccine production site

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France.

The new facility will allow Sanofi's vaccines unit, Sanofi Pasteur, to expand the supply of influenza vaccine VaxigripTetra, which is compliant with the World Health Organization's recommendation.

Sanofi plans to complete the expansion by 2021, subject to regulatory approvals, and will commence vaccine production in the new facility in 2022.

Sanofi Pasteur remains the sole influenza vaccine producer in France.